Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Industry Insights

Science and business issues impacting the China biotech industry...

InnoCare Completes Phase II Enrollment of TYK2 Inhibitor for Psoriasis

China Biotech Grows Up; Facts and Inferences from an In Vivo Sector Review

China Announces Plans to Facilitate Foreign Investments in its Biopharma Industry

ASCO: BioNTech and Merck Present Positive Data on China-Sourced Oncology Drugs

2022 China Life Science Deals: Slow Start, Late Recovery; Top 10 Deals Worth $21.5 Billion

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital